N/A N=34 Vasculera in Participants With Lipedema
Lipedema
Primary: Change in Weight From Baseline — 0.340 kilograms — p=0.473
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=22 Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)
Primary Open Angle Glaucoma (POAG)
Primary: Safety: Number of Patients Experiencing a Device Related SAE (SADE) and Complications During Implantation — 0; 9; 7 participants
N/A N=30 Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens
Myopia
Primary: Lens Handling at Insertion — 83; 93 score on a scale
Phase 1 N=11 Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test
Metabolic Diseases
Primary: Oral Glucose Sensitivity Index (Kisspeptin-Placebo) — 517; 521 ml min-1m-2
N/A N=32 Does Sound Conditioning Protect Against Temporary Hearing Damage
Hearing Loss, Noise-Induced
Primary: PTA (EF) — 7.06; 8.94; 7.94; 12.19 dB HL — p=< 0.0005
N/A N=655 Aortoiliac Stenosis in Kidney Transplantation
Aorto-Iliac Arterial Stenosis · Peripheral Arterial Disease · Kidney Transplant Failure
Primary: Patient Survival — 322; 48; 6 Participants
Phase 2 N=24 Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)
Warm Autoimmune Hemolytic Anemia · Cold Agglutinin Disease
Primary: Number of Subjects With Treatment Emergent Adverse Events (TEAEs) Including by Severity — 5; 5; 7; 6 Participants
N/A N=654 Evaluating Novel Approaches for Estimating Awake and Sleep Blood Pressure
Blood Pressure
Primary: Absolute Difference Between Unattended and Attended Blood Pressure — 119.5; 72.7; 118.7; 72.2 mm Hg — p=< 0.0001
Phase 3 N=84 Effect of Dexamethasone on Labor Induction
Dexamethasone · Pregnancy
Primary: First Bishop Score — 1; 1 score on a scale — p=0.618
N/A N=40 Clinical Evaluation of Hydrogel and Silicone Hydrogel Daily Disposable Toric Contact Lenses
Astigmatism
Primary: Subjective Handling at Insertion, Dispensing Visit — 87.13; 88.50 score on a scale
Phase 3 N=168 JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population
Temple Hollowing
Primary: Number of Participants With Adverse Events — 23; 59; 1; 2 Participants
N/A N=306 Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)
HIV · Hepatitis C · Opioid-use Disorder
Primary: Total Participants Who Received Referrals to the Harm Reduction Services Organization — 121 Participants
N/A N=42 Replaceability of Fluoroscopy and Ultrasound in the Evaluation of Hemidiaphragm Excursion
Diaphragm Disease
Primary: Diaphragm Function — 4.25 centimeters — p=<0.05
N/A N=105 Young Adult EC Use and Respiratory Outcomes
E Cig Use
Primary: Spirometry to Measure the Change From Baseline in Forced Vital Capacity (FVC) — 4.42; 3.54; 4.61; 3.68 liter
Phase 1 N=6 Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA)
Peripheral Artery Disease · Vascular Disease · Critical Limb Ischemia
Primary: Number of Participants With Treatment-related Adverse Events Occurring During the Enrollment Period as Assessed by the Investigator Using the CTCAE 4.0 Scale. — 2; 0…